Newsletter | October 21, 2026

10.21.26 -- The Case For Reciprocal Due Diligence In Life Sciences Board Recruitment

FEATURED ARTICLE

The Case For Reciprocal Due Diligence In Life Sciences Board Recruitment

Strong life sciences governance starts before a director joins the board. Reciprocal due diligence helps candidates assess culture, leadership relationships, conflict, and accountability before taking responsibility for decisions whose consequences may eventually reach patients.

 

INDUSTRY INSIGHTS

 

Flow Chemistry FAQ: Continuous Processing For Challenging API Chemistry

Continuous flow manufacturing improves API synthesis through precise mixing and thermal control. Small-volume reactions enhance safety, reduce waste, and ensure consistent product quality.

 

Maintain Compliance Through Divestiture Without Disrupting Operations

Facing a divestiture? Learn how to protect historical quality records and stay audit-ready throughout the transition. 

 

Optimizing Biologics Manufacturing Processes With Raw Materials

Improve your commercial manufacturing process with advice from regulatory and raw materials experts on the development journey from pre-clinical to licensure.

 

From Startup To Signal Detection: Building An Integrated Safety Framework

Early alignment, continuous collaboration, and unified decisions help teams spot safety signals sooner, streamline responses, cut amendments, and strengthen patient protection across clinical trials.

 

When Vendor Disruption Threatens Trial Timelines: What Sponsors Should Do Next

When vendors face disruptions, trials can be affected. Discover key questions to assess partner stability, strengthen operational resilience, and keep studies on track.

Connect With Life Science Leader: